7,852 press releases indexed under healthcare.
MORRISVILLE, N.C., Sept. 15, 2026 /PRNewswire/ -- Valeris, an integrated commercialization partner helping life sciences companies connect market access, patient services, and commercial strategy, today announced that Jeff Crowther has joined as Chief Revenue Officer, reporting to Chief...
Toronto, Ontario--(Newsfile Corp. - September 15, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company"), an Ontario-based organization advancing innovation and research within the legal psychedelic sector, is pleased to announce that its wholly owned subsidiary, Filament Health Corp. ("Filament"), has entered into a supply and licensing agreement with the University of Southern California, on behalf of its Keck School of Medicine of USC, for the...
The global non-invasive cancer diagnostics market was valued at USD 80.9 billion in 2025 and is expected to reach USD 85.8 billion in 2026. By [read full press release...]
MONTREAL, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. ("Knight") (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today that Knight’s New Drug Submission (NDS) for GEMTESA ® (vibegron), proposed for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults, and OAB with symptoms of urge urinary incontinence, urgency, urinary frequency, and nocturia in adult males on pharmacological therapy for benign prostatic hyperplasia (BPH), has been accepted for review by Health Canada.
Landmark Research Continues to Advance Home Blood Pressure Monitoring and Preventive Cardiovascular Care KYOTO, JAPAN - September 15, 2026 ( NEWMEDIAWIRE ) - OMRON Healthcare Co., Ltd., a global leader in clinically proven medical equipment for home health monitoring and treatment, has marked the 40th anniversary of the Ohasama Study, one of the world's longest-running community-based cardiovascular research projects. Ahead of World Heart Day (September 29), the milestone celebrates four decades of work that helped establish home blood pressure monitoring as a global standard for hypertension management and remains a driving force in preventive cardiovascular care through ongoing research. The Ohasama Study was launched in 1986 by a team from Tohoku University under the leadership of Profe
Healthcare has never had a shortage of information. The real challenge has been turning that information into decisions that improve care, control costs, and help [read full press release...]
(PR-inside.com) New Study Reveals Wildlife Crossings Can Provide Communities a 10-to-1 Return on Investment Through Healthier Natural Resources, Reduced Car Collisions and Saved Lives TALLAHASSEE, FL / ACCESS Newswire / September 15, 2026 / A new study commissioned by Live Wildly and prepared by engineering firm FDA | Prime AE has identified cost-saving ways Florida communities can construct wildlife crossings on local roads to protect natural resources and promote public safety - all while generating an estimated $10 in public benefits for every $1 invested. Photo Credits: fStop Foundation Collisions between vehicles and wildlife cause about 200 deaths, 26,000 injuries and more than ..
A drug candidate can spend years moving through discovery, preclinical testing, and clinical development before researchers know whether it will ultimately succeed. That uncertainty is [read full press release...]
Pivotal results from TRIUMPH-2 showed retatrutide, an investigational triple hormone receptor agonist, delivered substantial weight loss and A1C improvements in obesity and type 2 diabetes Findings from ACHIEVE-4, the largest and longest study of Foundayo in type 2 diabetes, reaffirmed...
Capricor Therapeutics, Inc. has been sued for securities fraud over alleged misstatements about Deramiocel and the integrity of the clinical data supporting its Biologics License Application leading to a 64% stock drop. NEW YORK, Sept. 15, 2026 /PRNewswire/ -- Leading securities law firm...
BFA Law is investigating whether Lululemon committed securities fraud by making false and misleading statements to investors regarding the strength of its growth and overall business health. NEW YORK, Sept. 15, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP...
A securities fraud class action lawsuit has been filed on behalf of Beta Bionics investors after its stock plummeted over 37% because Beta Bionics allegedly misled investors about the safety, efficacy, and commercial success of its iLet medical device, potentially violating the federal...